Gene Name |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
HMP19 protein |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine) ( 23648065)
- Subcutaneous adipose tissue ( 22589738)
|
Protein-Protein Interactions |
17 interactors:
ATXN7L3
CDH1
HMP19
LONRF1
NEDD8
PJA1
PLA2G2A
POGK
TRIM27
TRIM54
TRIM55
TRIM63
UBC
UBE2S
USP15
USP21
USP28
|
13 interactors:
APOC1
HCFC1R1
NDUFA2
RIF1
RPS27
SERPINH1
SLC35F6
STX18
SUPT4H1
TNNT1
TSPAN6
UCHL3
ZNF768
|
Entrez ID |
7347 |
51617 |
HPRD ID |
04367 |
13664 |
Ensembl ID |
ENSG00000118939
|
ENSG00000170091
|
Uniprot IDs |
P15374
|
Q9Y328
|
PDB IDs |
1UCH
1XD3
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
attempts
c2
canine
changed
chemokine
depends
eia3
eia4
epo
folding
gstt3
hours
hsp90
hypothetical
introduced
kit
masitinib
mast
neoplastic
pdia3
pro
proliferative
proteome
selenbp1
steroid
tardbp
transcriptionally
transcriptome
tumour
|
|
Tagcloud (Difference) ? |
attempts
c2
canine
changed
chemokine
depends
eia3
eia4
epo
folding
gstt3
hours
hsp90
hypothetical
introduced
kit
masitinib
mast
neoplastic
pdia3
pro
proliferative
proteome
selenbp1
steroid
tardbp
transcriptionally
transcriptome
tumour
|
|
Tagcloud (Intersection) ? |
|